title: Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats.
abstract: Ayahuasca is a hallucinogenic beverage that combines the action of the 5-HT2A/2C agonist N,N-dimethyltryptamine (DMT) from Psychotria viridis with the monoamine oxidase inhibitors (MAOIs) induced by beta-carbonyls from Banisteriopsis caapi. Previous investigations have highlighted the involvement of ayahuasca with the activation of brain regions known to be involved with episodic memory, contextual associations and emotional processing after ayahuasca ingestion. Moreover long term users show better performance in neuropsychological tests when tested in off-drug condition. This study evaluated the effects of long-term administration of ayahuasca on Morris water maze (MWM), fear conditioning and elevated plus maze (EPM) performance in rats. Behavior tests started 48h after the end of treatment. Freeze-dried ayahuasca doses of 120, 240 and 480 mg/kg were used, with water as the control. Long-term administration consisted of a daily oral dose for 30 days by gavage. The behavioral data indicated that long-term ayahuasca administration did not affect the performance of animals in MWM and EPM tasks. However the dose of 120 mg/kg increased the contextual conditioned fear response for both background and foreground fear conditioning. The tone conditioned response was not affected after long-term administration. In addition, the increase in the contextual fear response was maintained during the repeated sessions several weeks after training. Taken together, these data showed that long-term ayahuasca administration in rats can interfere with the contextual association of emotional events, which is in agreement with the fact that the beverage activates brain areas related to these processes.
authors.affiliation: Departamento de Psicobiologia, Universidade Federal de São Paulo - UNIFESP, São Paulo, SP, Brazil.
authors.forename: Vanessa Manchim
authors.initials: VM
authors.lastname: Favaro
authors.affiliation: Faculdade de Ciências Farmacêuticas, Departamento de Análises Clínicas e Toxicológicas, Universidade de São Paulo - USP, São Paulo, SP, Brazil.
authors.forename: Maurício
authors.initials: M
authors.lastname: Yonamine
authors.affiliation: Departamento de Psicobiologia, Universidade Federal de São Paulo - UNIFESP, São Paulo, SP, Brazil.
authors.forename: Juliana Carlota Kramer
authors.initials: JC
authors.lastname: Soares
authors.affiliation: Departamento de Psicobiologia, Universidade Federal de São Paulo - UNIFESP, São Paulo, SP, Brazil.
authors.forename: Maria Gabriela Menezes
authors.initials: MG
authors.lastname: Oliveira
mesh_terms: D000818:Animals; D001007:Anxiety / Q000139:chemically induced*; D031581:Banisteriopsis; D001628:Beverages; D003213:Conditioning, Psychological / Q000187:drug effects; D005239:Fear / Q000187:drug effects; D006213:Hallucinogens / Q000008:administration & dosage* / Q000737:chemistry; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D008568:Memory / Q000187:drug effects*; D010946:Plants, Medicinal; D051381:Rats; D017208:Rats, Wistar
chemical_list: D006213:Hallucinogens